OXBDFOxford Biomedica PLC

About Oxford Biomedica PLC (OXBDF)

Oxford Biomedica PLC (OXBDF) is a Biotechnology company headquartered in Oxford, ENG, United Kingdom whose shares trade over-the-counter on the Pink tier.

Oxford Biomedica is a leading, fully integrated, gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford Biomedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, CNS disorders, liver diseases and respiratory disease.

OXBDF key facts

Ticker symbol

OXBDF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Oxford, ENG, United Kingdom

Estimated market cap

$327.81M (as of May 13, 2025)

Shares outstanding

83,484,173

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with O